Package 42794-003-08

Brand: adefovir dipivoxil

Generic: adefovir dipivoxil
NDC Package

Package Facts

Identity

Package NDC 42794-003-08
Digits Only 4279400308
Product NDC 42794-003
Description

1 BOTTLE in 1 CARTON (42794-003-08) / 30 TABLET in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2016-07-18
Brand adefovir dipivoxil
Generic adefovir dipivoxil
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f7ac2b46-04c8-a739-e053-6394a90a7711", "openfda": {"upc": ["0342794003080"], "unii": ["U6Q8Z01514"], "rxcui": ["881341"], "spl_set_id": ["e047f3b2-feae-4c5e-9d07-1fefb4c0ec25"], "manufacturer_name": ["Sigmapharm Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (42794-003-08)  / 30 TABLET in 1 BOTTLE", "package_ndc": "42794-003-08", "marketing_start_date": "20160718"}], "brand_name": "ADEFOVIR DIPIVOXIL", "product_id": "42794-003_f7ac2b46-04c8-a739-e053-6394a90a7711", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "42794-003", "generic_name": "ADEFOVIR DIPIVOXIL", "labeler_name": "Sigmapharm Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ADEFOVIR DIPIVOXIL", "active_ingredients": [{"name": "ADEFOVIR DIPIVOXIL", "strength": "10 mg/1"}], "application_number": "ANDA202051", "marketing_category": "ANDA", "marketing_start_date": "20130903", "listing_expiration_date": "20261231"}